Skip to main content
. Author manuscript; available in PMC: 2023 Jan 1.
Published in final edited form as: World Neurosurg. 2021 Oct 7;157:e179–e187. doi: 10.1016/j.wneu.2021.09.121

Table 1.

Baseline patient characteristics (n=695)

Variable Count (%) or mean (range)
Male 313 (45%)
Age, years 86 (80–99)
Race
 White 578 (83%)
 Black 45 (7%)
 Asian 22 (3%)
 Other/Unknown 50 (7%)
PMH
 Neuro 328 (47%)
  Dementia 165 (24%)
  Prior TBI 32 (5%)
 CHF 104 (15%)
 CAD 196 (28%)
 COPD 71 (10%)
 ESRD 17 (2%)
 Cirrhosis 3 (0.4%)
 Diabetes 196 (28%)
 Substance abuse 14 (2%)
Anticoagulant use 163 (24%)
Antiplatelet use 377 (54%)
Mechanism of injury
 Found down 41 (6%)
 Fall >10ft 12 (2%)
 Fall <10ft 592 (85%)
 MVC 23 (3%)
 Other/Unknown 27 (4%)
GCS
 3–8 76 (11%)
 9–12 56 (8%)
 13–15 563 (81%)
ISS 17 (1–38)
Pupillary reactivity
 Both reactive 636 (92%)
 None reactive 38 (6%)
 One reactive 21 (3%)
Subdural hematoma
 Acute 660 (95%)
 Subacute 21 (3%)
 Chronic 12 (2%)
Epidural hematoma 13 (2%)
IVH 38 (6%)
SAH 215 (31%)
Contusion 84 (12%)
DAI 1 (0.1%)
Skull fracture 48 (7%)

Abbreviations: PMH - past medical history; TBI - traumatic brain injury; CHF - congestive heart failure; CAD - coronary artery disease; COPD - chronic obstructive pulmonary disease; ESRD - end-stage renal disease; GCS - Glasgow coma scale; ISS - injury severity scale; IVH - intraventricular hemorrhage; SAH - subarachnoid hemorrhage; DAI - diffuse axonal injury